HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders

Archive ouverte

Le Clerc, Sigrid | Lombardi, Laura | Baune, Bernhard, T | Amare, Azmeraw, T | Schubert, Klaus Oliver | Hou, Liping | Clark, Scott, R | Papiol, Sergi | Cearns, Micah | Heilbronner, Urs | Degenhardt, Franziska | Tekola-Ayele, Fasil | Hsu, Yi-Hsiang | Shekhtman, Tatyana | Adli, Mazda | Akula, Nirmala | Akiyama, Kazufumi | Ardau, Raffaella | Arias, Bárbara | Aubry, Jean-Michel | Backlund, Lena | Bhattacharjee, Abesh Kumar | Bellivier, Frank | Benabarre, Antonio | Bengesser, Susanne | Biernacka, Joanna, M | Birner, Armin | Brichant-Petitjean, Clara | Cervantes, Pablo | Chen, Hsi-Chung | Chillotti, Caterina | Cichon, Sven | Cruceanu, Cristiana | Czerski, Piotr, M | Dalkner, Nina | Dayer, Alexandre | del Zompo, Maria | Depaulo, J. Raymond, Raymond | Étain, Bruno | Jamain, Stephane | Falkai, Peter | Forstner, Andreas, J | Frisen, Louise | Frye, Mark, A | Fullerton, Janice, M | Gard, Sébastien | Garnham, Julie, S | Goes, Fernando, S | Grigoroiu-Serbanescu, Maria | Grof, Paul | Hashimoto, Ryota | Hauser, Joanna | Herms, Stefan | Hoffmann, Per | Jiménez, Esther | Kahn, Jean-Pierre | Kassem, Layla | Kuo, Po-Hsiu | Kato, Tadafumi | Kelsoe, John, R | Kittel-Schneider, Sarah | Ferensztajn-Rochowiak, Ewa | König, Barbara | Kusumi, Ichiro | Laje, Gonzalo | Landén, Mikael | Lavebratt, Catharina | Leckband, Susan, G | Tortorella, Alfonso | Manchia, Mirko | Martinsson, Lina | Mccarthy, Michael, J | Mcelroy, Susan, L | Colom, Francesc | Millischer, Vincent | Mitjans, Marina | Mondimore, Francis, M | Monteleone, Palmiero | Nievergelt, Caroline, M | Nöthen, Markus, M | Novák, Tomas | O’donovan, Claire | Ozaki, Norio | Ösby, Urban | Pfennig, Andrea | Potash, James, B | Reif, Andreas | Reininghaus, Eva | Rouleau, Guy, A | Rybakowski, Janusz, K | Schalling, Martin | Schofield, Peter, R | Schweizer, Barbara, W | Severino, Giovanni | Shilling, Paul, D | Shimoda, Katzutaka | Simhandl, Christian | Slaney, Claire, M | Pisanu, Claudia | Squassina, Alessio | Stamm, Thomas | Stopkova, Pavla | Maj, Mario | Turecki, Gustavo | Vieta, Eduard | Veeh, Julia | Witt, Stephanie, H | Wright, Adam | Zandi, Peter, P | Mitchell, Philip, B | Bauer, Michael | Alda, Martin | Rietschel, Marcella | Mcmahon, Francis, J | Schulze, Thomas, G | Spadoni, Jean-Louis | Boukouaci, Wahid | Richard, Jean-Romain | Le Corvoisier, Philippe | Barrau, Caroline | Zagury, Jean-François | Leboyer, Marion | Tamouza, Ryad

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract Bipolar affective disorder (BD) is a severe psychiatric illness, for which lithium (Li) is the gold standard for acute and maintenance therapies. The therapeutic response to Li in BD is heterogeneous and reliable biomarkers allowing patients stratification are still needed. A GWAS performed by the International Consortium on Lithium Genetics (ConLiGen) has recently identified genetic markers associated with treatment responses to Li in the human leukocyte antigens (HLA) region. To better understand the molecular mechanisms underlying this association, we have genetically imputed the classical alleles of the HLA region in the European patients of the ConLiGen cohort. We found our best signal for amino-acid variants belonging to the HLA-DRB1*11:01 classical allele, associated with a better response to Li ( p < 1 × 10 −3 ; FDR < 0.09 in the recessive model). Alanine or Leucine at position 74 of the HLA-DRB1 heavy chain was associated with a good response while Arginine or Glutamic acid with a poor response. As these variants have been implicated in common inflammatory/autoimmune processes, our findings strongly suggest that HLA-mediated low inflammatory background may contribute to the efficient response to Li in BD patients, while an inflammatory status overriding Li anti-inflammatory properties would favor a weak response.

Suggestions

Du même auteur

Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

Archive ouverte | Amare, Azmeraw, T | CCSD

International audience. Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithi...

Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

Archive ouverte | Amare, Azmeraw | CCSD

International audience. Lithium is a first-line medication for bipolar disorder (BD), but only one in three patients respond optimally to the drug. Since evidence shows a strong clinical and genetic overlap between ...

Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach

Archive ouverte | Cearns, Micah | CCSD

International audience. Background Response to lithium in patients with bipolar disorder is associated with clinical and transdiagnostic genetic factors. The predictive combination of these variables might help clin...

Chargement des enrichissements...